Gene Therapy for X-Linked Retinitis Pigmentosa (IMAGE)

University of Pennsylvania

Gene Therapy for X-Linked Retinitis Pigmentosa

Caption

Using gene therapy to augment normal levels of the RPGR gene resulted in long-term rescue of photoreceptors within the retinal region of gene therapy injection, but not within the control injection. The rescue lasted at least 2.5 years when the disease was treated in its later stages.

Credit

University of Pennsylvania

Usage Restrictions

In context of reporting

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.